Pro Dex director acquires 19 shares via ESPP
Pro Dex Inc director Angelita Rebamontan acquired 19 shares of common stock on July 23, 2026 at $33.25 per share through an Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c) and Rule 16b-3(d).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Pro Dex Inc director Angelita Rebamontan acquired 19 shares of common stock on July 23, 2026 at $33.25 per share through an Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c) and Rule 16b-3(d). After this acquisition, she directly holds 18,798 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 19 | $33.25 | $631.75 |
Footnotes (1)
- F1. These purchases were made pursuant to an Employee Stock Purchase Plan in exempt transactions pursuant to Rule 16b-3(c) and Rule 16b-3(d).
Key Figures
Key Terms
Employee Stock Purchase Plan financial
Rule 16b-3(c) regulatory
Rule 16b-3(d) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Pro Dex (PDEX) director Angelita Rebamontan report in this Form 4?
Was the Pro Dex (PDEX) director’s transaction made under an Employee Stock Purchase Plan?
Is the Pro Dex (PDEX) Form 4 transaction reported as a 10b5-1 trading plan trade?
AI-generated analysis. How Rhea-AI works. Not financial advice.